KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) EBIT (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -68.28%
Dec 28, 2025 185.27%
Sep 28, 2025 5.82%
Jun 29, 2025 7.51%
Mar 30, 2025 71.77%
Dec 29, 2024 -28.55%
Sep 29, 2024 -22.15%
Jun 30, 2024 9.49%
Mar 31, 2024 -68.66%
Dec 31, 2023 228.45%
Oct 1, 2023 -1.26%
Jul 2, 2023 1.70%
Apr 2, 2023 -40.51%
Jan 1, 2023 81.32%
Oct 2, 2022 36.61%
Jul 3, 2022 -10.87%
Oct 3, 2021 6.51%
Jul 4, 2021 -5.96%
Apr 4, 2021 -19.02%
Jan 3, 2021 41.12%
Sep 27, 2020 44.42%
Jun 28, 2020 -30.96%
Mar 29, 2020 41.48%
Dec 29, 2019 -29.71%
Sep 29, 2019 8.72%
Jun 30, 2019 1.13%
Mar 31, 2019 32.62%
Dec 30, 2018 -27.67%
Sep 30, 2018 3.24%
Jul 1, 2018 -4.91%
Apr 1, 2018 89.64%
Dec 31, 2017 -34.57%
Oct 1, 2017 -14.20%
Jul 2, 2017 -1.55%
Apr 2, 2017 17.66%
Jan 1, 2017 -13.59%
Oct 2, 2016 -5.21%
Jul 3, 2016 4.70%
Apr 3, 2016 -53.97%
Jan 3, 2016 148.72%
Sep 27, 2015 -5.57%
Jun 28, 2015 -8.02%
Mar 29, 2015 35.55%
Dec 28, 2014 -29.28%
Sep 28, 2014 -6.58%
Jun 29, 2014 5.74%
Mar 30, 2014 38.65%
Dec 29, 2013 -16.47%
Sep 29, 2013 -3.77%
Jun 30, 2013 2.47%
Mar 31, 2013 19.08%
Dec 30, 2012 -3.53%
Sep 30, 2012 -6.46%
Jul 1, 2012 0.81%
Apr 1, 2012 203.05%
Jan 1, 2012 -61.58%
Oct 2, 2011 4.84%
Jul 3, 2011 -18.74%
Apr 3, 2011 -56.61%
Jan 2, 2011 163.65%
Oct 3, 2010 -6.38%
Jul 4, 2010 -9.88%
Apr 4, 2010 116.98%
Jan 3, 2010 -48.46%
Sep 27, 2009 -2.09%
Jun 28, 2009 -6.35%